LITTLE FALLS, N.J.,
Dec. 3, 2020 /PRNewswire/
-- CANTEL MEDICAL CORP. (NYSE:CMD) announced today the
appointment of Andy Xilas to
President, Cantel Dental effective January
1, 2021. He will be taking over for Ken Serota, who will be stepping down as
President effective December 31,
2020. In addition, Jennifer
Naylor has been appointed to the newly created role of
Senior Vice President, Infection Prevention and Control Strategy
and Education for Cantel. Mr. Xilas and Ms. Naylor both joined
Cantel in 2019, as part of Cantel's acquisition of Hu-Friedy and
will sit on the Company's Executive Leadership Team.
Mr. Xilas has held various positions at Hu-Friedy with
increasing responsibility over the past 33 years. He most recently
led the Instrument business as well as the EMEA and APAC regions.
He has built a strong reputation as a results-focused global
business leader with a successful track record of growth and
expansion in key markets. Mr. Xilas is a trusted colleague with
strong customer relationships critical for driving collaboration
and business growth and is the ideal candidate to lead and grow
Cantel Dental.
Ms. Naylor has held various leadership positions over the past
19 years with Hu-Friedy, most recently serving as the Chief
Commercial Officer. In her newly created role, Ms. Naylor will
utilize her robust Infection Prevention & Control (IP&C)
expertise to identify and develop new IP&C growth strategies
leveraging our capabilities across our existing business and
adjacencies. She will also be focused on driving Cantel leadership
in IP&C education and training, drawing on best practices
across Cantel's individual businesses. Due to the COVID-19
pandemic, Infection Prevention has never been more relevant, and
this key role will help accelerate our mission of Infection
Prevention and Control into the future.
"I want to thank Ken for his leadership and significant
contributions to the Company," said George
Fotiades, CEO. "Ken was instrumental in the process that
brought together the Hu-Friedy Company and Crosstex under the
Cantel umbrella, as well as helping build and secure HuFriedy
Group's premier industry position. In particular, Ken's support has
been invaluable in helping us successfully navigate the challenges
of the pandemic. He leaves in place a great leadership team capable
of continuing the growth of Cantel Dental. I would like to
congratulate both Andy and Jennifer on their appointments. I am
confident given Andy's industry experience and Jennifer's unique
IP&C skillset, they will leverage their expertise to accelerate
the next phase of Cantel's development."
About Cantel Medical:
Cantel Medical is a leading
global company dedicated to delivering innovative infection
prevention products and services for patients, caregivers, and
other healthcare providers which improve outcomes, enhance safety
and help save lives. Our products include specialized medical
device reprocessing systems for endoscopy and renal dialysis,
advanced water purification equipment, sterilants, disinfectants
and cleaners, sterility assurance monitoring products for hospitals
and dental clinics, disposable infection control products primarily
for dental and GI endoscopy markets, instruments and instrument
reprocessing workflow systems serving the dental industry,
dialysate concentrates, hollow fiber membrane filtration and
separation products. Additionally, we provide technical service for
our products.
For further information, visit www.cantelmedical.com.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/cantel-announces-senior-leadership-promotions-in-dental-301185194.html
SOURCE Cantel Medical Corp.